Efficacy and Safety of Donepezil Hydrochloride in Preadolescent and Adolescent Children With Attention Impairment Following Cancer Treatment

Phase 3 Completed 72 enrolled Eisai Inc.

RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to evaluate the efficacy, safety and tolerability of donepezil in children with persistent attention impairment that is present at least 12 months after the completion of cancer treatment.

Timeline

Start: 2008-07-02
Primary completion: 2009-05-26
Completion: 2009-05-26

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Donepezil	Small molecule	3 mg	Oral
Subject	Donepezil	Small molecule	5 mg	Oral
Subject	Donepezil	Small molecule	10 mg	Oral

Efficacy and Safety of Donepezil Hydrochloride in Preadolescent and Adolescent Children With Attention Impairment Following Cancer Treatment

Summary

Timeline

Drugs

Indications